Tudor Investment Corp ET AL raised its stake in Vitamin Shoppe, Inc (NYSE:VSI) by 122.7% during the first quarter, Holdings Channel reports. The institutional investor owned 28,500 shares of the specialty retailer’s stock after buying an additional 15,700 shares during the period. Tudor Investment Corp ET AL’s holdings in Vitamin Shoppe were worth $574,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of the company. Mason Street Advisors LLC boosted its stake in Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in shares of Vitamin Shoppe during the first quarter worth about $208,000. Arizona State Retirement System increased its position in shares of Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock worth $249,000 after buying an additional 100 shares in the last quarter. Allianz Asset Management AG purchased a new position in shares of Vitamin Shoppe during the fourth quarter worth about $252,000. Finally, Stevens Capital Management LP increased its position in shares of Vitamin Shoppe by 15.3% in the first quarter. Stevens Capital Management LP now owns 14,415 shares of the specialty retailer’s stock worth $290,000 after buying an additional 1,909 shares in the last quarter.
Shares of Vitamin Shoppe, Inc (NYSE:VSI) opened at 11.45 on Monday. The firm’s 50-day moving average price is $11.54 and its 200-day moving average price is $18.74. The firm has a market capitalization of $265.22 million, a price-to-earnings ratio of 14.74 and a beta of 0.69. Vitamin Shoppe, Inc has a 12 month low of $9.80 and a 12 month high of $32.31.
Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, May 10th. The specialty retailer reported $0.37 EPS for the quarter, missing the consensus estimate of $0.58 by $0.21. Vitamin Shoppe had a net margin of 1.43% and a return on equity of 9.35%. The company had revenue of $316.90 million for the quarter, compared to analyst estimates of $325.71 million. During the same period last year, the company posted $0.67 earnings per share. The business’s revenue for the quarter was down 5.9% on a year-over-year basis. On average, equities analysts anticipate that Vitamin Shoppe, Inc will post $1.57 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “Vitamin Shoppe, Inc (NYSE:VSI) Shares Bought by Tudor Investment Corp ET AL” was published by WKRB News and is the property of of WKRB News. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.wkrb13.com/markets/2284999/vitamin-shoppe-inc-nysevsi-shares-bought-by-tudor-investment-corp-et-al.html.
Several brokerages have recently weighed in on VSI. Zacks Investment Research downgraded shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Wednesday, May 3rd. Goldman Sachs Group, Inc. (The) reduced their target price on shares of Vitamin Shoppe from $22.00 to $19.00 and set a “sell” rating on the stock in a report on Thursday, March 23rd. Gabelli downgraded shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Thursday, May 11th. Morgan Stanley raised shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 target price for the company in a research report on Thursday, May 11th. Finally, Barclays PLC reaffirmed an “equal weight” rating and issued a $13.00 price objective (down previously from $24.00) on shares of Vitamin Shoppe in a research report on Sunday, May 14th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $24.00.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe, Inc (NYSE:VSI).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284999/vitamin-shoppe-inc-nysevsi-shares-bought-by-tudor-investment-corp-et-al.html
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.